Nanotechnology and immunoengineering: How nanotechnology can boost CAR-T therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanotechnology and immunoengineering: How nanotechnology can boost CAR-T therapy

Published:2020-06 Issue: Volume:109 Page:21-36
ISSN:1742-7061
Container-title:Acta Biomaterialia
language:en
Short-container-title:Acta Biomaterialia

Author:

Nawaz Waqas,Xu Shijie,Li Yanlei,Huang Bilian,Wu Xilin,Wu Zhiwei

Funder

Six Talent Peaks Project in Jiangsu Province

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology

Reference193 articles.

1. Treating B-cell cancer with t cells expressing anti-CD19 chimeric antigen receptors, nature reviews;Kochenderfer;Clin. Oncol.,2013

2. CD19-CAR trials;Ramos;Cancer J.,2014

3. CD19-targeted t cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia;Brentjens;Sci. Transl. Med.,2013

4. Axicabtagene ciloleucel car T-Cell therapy in refractory large B-Cell lymphoma;Neelapu;N. Engl. J. Med.,2017

5. Chimeric antigen receptor t cells in refractory B-Cell lymphomas;Schuster;N. Engl. J. Med.,2017

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficient Capture and Traceless Release of Functional CD8⁺ T Cells with a Microfluidic Chip for Enhanced In Vitro and In Vivo CD4-CAR Transduction;Analytical Chemistry;2024-09-13

2. Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/NK cell therapy;Bioengineering & Translational Medicine;2024-08-31

3. Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment;eBioMedicine;2024-08

4. Atypical artificial cells: Novel biomimetic materials for combating cancer;Interdisciplinary Materials;2024-07-17

5. The paths toward non-viral CAR-T cell manufacturing: A comprehensive review of state-of-the-art methods;Life Sciences;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3